1. Apoptosis
  2. Apoptosis TNF Receptor
  3. Cusatuzumab

Cusatuzumab  (Synonyms: ARGX-110)

Cat. No.: HY-P99014 Purity: 98.80%
Data Sheet Technical Support

Cusatuzumab (ARGX-110) is a human αCD70 monoclonal antibody. Cusatuzumab has the activity of enhancied antibody-dependent cellular cytotoxicity (ADCC). Cusatuzumab blocks the CD70/CD27 signaling pathway, reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab can be used to study leukemia.

For research use only. We do not sell to patients.

CAS No. : 1864871-20-4

Size Price Stock Quantity
1 mg USD 322 In-stock
5 mg USD 710 In-stock
10 mg   Get quote  
50 mg   Get quote  

Get it by April 8 for select sizes. Order within 23 hrs 24 mins.

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Cusatuzumab

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Cusatuzumab (ARGX-110) is a human αCD70 monoclonal antibody. Cusatuzumab has the activity of enhancied antibody-dependent cellular cytotoxicity (ADCC). Cusatuzumab blocks the CD70/CD27 signaling pathway, reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab can be used to study leukemia[1].

In Vitro

Cusatuzumab (10 μg/mL; 14 days) can inhibit colony formation of leukemia stem cells in vitro[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Cusatuzumab (intraperitoneal injection; 10 mg/kg; 3 times) can reduce leukemia cell colonization and LSC number, and the effect is better in the presence of NK cells in NSG mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Patient bone marrow cells treated sublethally irradiated NSG mice[1]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.); 3 times within a week
Result: Was similarly effective in reducing leukemia cell engraftment and LSC numbers as the blocking αCD70 mAb in the absence of NK cells.
Further reduced leukemia engraftment and LSC numbers in the bone marrow and spleen in the presence of NK cells.
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT04023526OncoVerity, Inc.|argenx|Janssen Research & Development, LLC
Leukemia, Myeloid, Acute
July 29, 2019Phase 2
NCT04150887OncoVerity, Inc.|argenx|Janssen Research & Development, LLC
Leukemia, Myeloid, Acute
December 23, 2019Phase 1
NCT04241549OncoVerity, Inc.|argenx|Janssen Pharmaceutical K.K.
Leukemia, Myeloid, Acute
March 25, 2020Phase 1
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Cusatuzumab]

Shipping

Shipping with dry ice.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Format
  • Human IgG1 lambda2
Purity & Documentation

Purity: 98.80%

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Cusatuzumab
Cat. No.:
HY-P99014
Quantity:
MCE Japan Authorized Agent: